I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive ...
The two medication treatment types that are mainly prescribed for an OAB are antimuscarinic agents (like oxybutynin and ...
A recent decision from the U.S. District Court for the District of Delaware highlights an unsuccessful, yet creative Section 101 challenge. This ...
A newly FDA-cleared implant about half the length of a stick of chewing gum is offering a new treatment option for people ...
I need to urinate at least every two hours.
Demand for home-based medical technologies is expected to grow significantly over the next decade. ... Read More The post Ageing Asia fuels demand for wearable therapies as Australian device enters ...
I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive ...
I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive bladder. I need to urinate at least every two hours. Often there is a ...
GLEN DALE, W.Va. — Reynolds Memorial Hospital has performed its first implantation of the Altaviva device, a new treatment option designed to help manage bladder control symptoms.Hospital officials ...
FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal clinical study was selected for presentation on the ...
Copies of Astellas Pharma Inc.‘s Myrbetriq ER proposed by Ascent Pharmaceuticals Inc. infringe four patents for the overactive-bladder drug, a federal judge ruled, delaying their launch until 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results